Afficher la couverture 'Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | Le Heron, Louis' en grand format
/5

0 avis

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

Archive ouverte

Le Heron, Louis | Guillaume, Christine | Velard, Frédéric | Braux, Julien | Touqui, Lhousseine | Moriceau, Sandra | Sermet-Gaudelus, Isabelle | Laurent-Maquin, Dominique | Jacquot, Jacky

Edité par CCSD ; Elsevier -

International audience. Bone loss is an important clinical issue in patients with cystic fibrosis (CF). Whether the cystic fibrosis transmembrane conductance regulator (CFTR) plays a direct role in bone cell function is yet unknown. In this study, we provide evidence that inhibition of CFTR-Cl(-) channel function results in a significant decrease of osteoprotegerin (OPG) secretion accompanied with a concomitant increase of prostaglandin (PG) E(2) secretion of primary human osteoblast cultures (n=5). Our data therefore suggest that in bone cells of CF patients, the loss of CFTR activity may result in an increased inflammation-driven bone resorption (through both the reduced OPG and increased PGE(2) production), and thus might contribute to the early bone loss reported in young children with CF.

Suggestions

Du même auteur

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis

Archive ouverte | Delion, Martial | CCSD

International audience. Bone fragility and loss are a significant cause of morbidity in patients with cystic fibrosis (CF), and the lack of effective therapeutic options means that treatment is more often palliative...

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Archive ouverte | Velard, Frédéric | CCSD

International audience

Strontium-Substituted Bioceramics Particles: A New Way to Modulate MCP-1 and Gro-α Production by Human Primary Osteoblastic Cells

Archive ouverte | Braux, Julien | CCSD

International audience. To avoid morbidity and limited availability associated with autografts, synthetic calcium phosphate (CaP) ceramics were extensively developed and used as bone filling materials. Controlling t...

Chargement des enrichissements...